StockData
MIRA Pharmaceuticals, Inc. logo

MIRA Pharmaceuticals, Inc. (MIRA) stock

MIRANasdaqPharmaceutical Preparations
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 7/30
$0.29−0.08 (-20.99%)

Close on Nov 20, 2026Market cap $12.23MP/E –Yield –

Earnings

MIRA Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of MIRA Pharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

MIRA Pharmaceuticals has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When MIRA Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases MIRA Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. Update
  2. Update
  3. Update
  4. Update
  5. Update
  6. Update
  7. Update
  8. Update
  9. Update
  10. Update
  11. Update
  12. Update
  13. Update
  14. Update
  15. Update

See a number that looks wrong?